|View printer-friendly version|
Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference
BOULDER, Colo., Aug. 28 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Thomas Weisel Partners Healthcare Conference on September 8 in Boston. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.
Event: Thomas Weisel Partners Healthcare Conference 2006
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.